Current Strategies for Identifying and Validating Targets for New Treatment-Shortening Drugs for TB

E-ISSN： 1875-5666|7|3|297-307

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.7, Iss.3, 2007-05, pp. : 297-307

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Strategies in TB Immunotherapy

Current Molecular Medicine, Vol. 7, Iss. 4, 2007-06 ,pp. : 373-386

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Disability in Peripheral Arterial Disease: New Drugs

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 4, Iss. 3, 2004-09 ,pp. : 227-231

Bentham Science Publishers

Access to resources Recommend Favorite

Current Molecular Understanding and Future Treatment Strategies for Pathologic Ocular Neovascularization

Current Molecular Medicine, Vol. 9, Iss. 8, 2009-11 ,pp. : 973-981

Bentham Science Publishers

Access to resources Recommend Favorite

Serine Kinases as New Drug Targets for the Treatment of Type 2 Diabetes

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 5, Iss. 6, 2005-12 ,pp. : 529-536

Bentham Science Publishers

Access to resources Recommend Favorite

Innate immunity creates hope for new strategies in treatment of infections

By Garred P.

Immunology Today, Vol. 21, Iss. 11, 2000-11 ,pp. : 531-531

Elsevier

Access to resources Recommend Favorite